ArticleJournal of oral and maxillofacial pathology : JOMFP
Comparative analysis of oral manifestations of Covid 19.
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Covid patients experience changes in overall health and very less is known about variation in oral manifestations as per severity of Covid and how far it differs, which needs evaluation. Aim: To analyse COVID-19 hospitalized patients for variations in clinical, demographic details, and oral manifestations as per severity of involvement (mild, moderate, and severe). Patients and Methods: This prospective study had 12 participants of RT-PCR positive COVID in each group, and hence, 36 participants were selected for mild, moderate, and severe cases. All patients' data were noted from the first day of hospitalization until completion of treatment, with a follow-up of a minimum of 7 days. Results: In our study, the M: F ratio was 5:4 with a mean age of 39.44 years. The most common oral sites involved were labial mucosa, followed by buccal mucosa. In all mild, moderate, and severe cases, there was a significant association of labial mucosa ( Conclusion: Results show that oral manifestations and the well-being of patients worsen from mild to severe cases of COVID-19, poor oral hygiene, and multiple drug therapy for illness contribute to the same. These findings have significant implications for understanding oral manifestations as per variation in severity of COVID-19, with a multidisciplinary approach for management of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.